Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PCSK6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KALRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WFDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF710 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYPLA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GALT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMG3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NENF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYB561D2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DISC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00592 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on